Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.58 USD
Change Today 0.00 / 0.00%
Volume 70.6K
CBMX On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 06/29/15 All times are local (Market data is delayed by at least 15 minutes).

combimatrix corp (CBMX) Snapshot

Open
$1.60
Previous Close
$1.58
Day High
$1.62
Day Low
$1.49
52 Week High
07/22/14 - $2.70
52 Week Low
10/6/14 - $1.09
Market Cap
20.0M
Average Volume 10 Days
28.3K
EPS TTM
$-0.84
Shares Outstanding
12.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for COMBIMATRIX CORP (CBMX)

Related News

No related news articles were found.

combimatrix corp (CBMX) Related Businessweek News

No Related Businessweek News Found

combimatrix corp (CBMX) Details

CombiMatrix Corporation provides molecular diagnostic solutions and clinical support services. It offers DNA-based testing for the detection of genetic abnormalities. The company develops and markets molecular testing services in areas of miscarriage analysis, prenatal genetics, and postnatal developmental disorders in children. It serves commercial insurance companies, healthcare institutions, government payors, and individuals. CombiMatrix Corporation was founded in 1995 and is headquartered in Irvine, California.

56 Employees
Last Reported Date: 03/17/15
Founded in 1995

combimatrix corp (CBMX) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $301.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $255.3K
Compensation as of Fiscal Year 2014.

combimatrix corp (CBMX) Key Developments

CombiMatrix Corporation Presents at 5th LD Micro Invitational Conference, Jun-01-2015 08:00 AM

CombiMatrix Corporation Presents at 5th LD Micro Invitational Conference, Jun-01-2015 08:00 AM. Venue: Luxe Sunset Boulevard Hotel, 11461 Sunset Blvd, Los Angeles, CA 90049, United States. Speakers: Mark D. McDonough, Chief Executive Officer, President and Director.

CombiMatrix Corporation Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015

CombiMatrix Corporation announced unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported total revenues of $2,329,000 against $1,822,000 for the same period a year ago, the increase in Revenue was driven primarily by increased volumes of both microarray and non-microarray diagnostic tests, partially offset by a reduction in oncology volumes and revenues as the company exited that business during 2014. Excluding oncology, total revenues grew by 35%. Volume and revenue growth in the non-array business was driven primarily by volumes growth from the Sequenom collaboration, as well as from improved reimbursement from third-party payers for those tests. Operating loss was $1,748,000 against $1,985,000 for the same period a year ago. Net loss attributable to common stockholders was $2,655,000 against $1,996,000 for the same period a year ago. Basic and diluted net loss per share attributable to common stockholders was $0.23 against $0.18 for the same period a year ago. Net cash flows used in operations were $1.57 million compared to $1.60 million a year ago. The reduction in net loss in the first quarter of 2015 was driven primarily by increased revenues and lower litigation expenses, partially offset by continued investment in revenue-generating departments and increased cost of services. For the quarter ended March 31, 2015, net cash used in operating activities was $1.2 million, compared to $1.6 million in the comparable 2014 period. The decrease in net cash used in operating activities was due primarily to record cash reimbursement realized during the quarter, coupled with reduced legal expenses and favorable timing of vendor payments for inventory supplies and related costs.

CombiMatrix Corporation to Report Q1, 2015 Results on May 07, 2015

CombiMatrix Corporation announced that they will report Q1, 2015 results at 4:30 PM, US Eastern Standard Time on May 07, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CBMX:US $1.58 USD 0.00

CBMX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CBMX.
View Industry Companies
 

Industry Analysis

CBMX

Industry Average

Valuation CBMX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.2x
Price/Book 1.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact COMBIMATRIX CORP, please visit www.combimatrix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.